Eli Lilly and Company shares reached a record $1,311.75 during trading Oct. 20 and closed 3.49% higher, ahead of the drugmaker’s third-quarter results scheduled for Oct. 29.
The stock finished at $1,283.66, a gain of $43.32 from the previous close, according to historical trading data from S&P Global Market Intelligence. The previous intraday peak was $1,292.65 on Aug. 19.
By 11 a.m. ET (15:00 UTC), Lilly shares were up about 5%. The gain had narrowed to 3.49% by the close.
Lilly said it will release third-quarter results Oct. 29 and hold a conference call at 10 a.m. ET (14:00 UTC).
